Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04431947
Other study ID # 20-0375
Secondary ID K12DK094712
Status Completed
Phase
First received
Last updated
Start date March 13, 2020
Est. completion date April 1, 2022

Study information

Verified date April 2022
Source University of Colorado, Denver
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study evaluates the impact of the hybrid closed-loop insulin delivery systems on sleep in youth with type 1 diabetes and their parents. Activity watches, surveys and device downloads are used to evaluate sleep in these participants.


Description:

Sleep is important for everyone, including youth with type 1 diabetes. New technology has shown improvements in glycemic variability, especially overnight. This study evaluates the impact of advanced hybrid closed-loop insulin delivery systems on sleep for both youth with type 1 diabetes and their parents. Study measures include wearing an actigraphy watch and completing a sleep diary for 7 days and taking surveys on sleep and psychosocial measures. Study measures occur prior to starting the hybrid closed-loop system, immediately after starting the system and at 3 and 6 months after starting the system.


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date April 1, 2022
Est. primary completion date April 1, 2022
Accepts healthy volunteers
Gender All
Age group 2 Years to 17 Years
Eligibility Inclusion Criteria: - Child diagnosed with type 1 diabetes for at least 3 months - Child receives clinical care at the Barbara Davis Center for Diabetes - Child starting an advanced HCL system as part of routine diabetes care - Child currently living with a parent who is willing to complete surveys for this study - Family able to read and speak English - Parent lives at home with the child with type 1 diabetes - Parent able to read and speak English Exclusion Criteria: - Child has an active underlying sleep disorder, such as narcolepsy, insomnia or untreated sleep apnea - Child participating in an interventional research protocol - Child unable to complete study procedures - Parent has an active underlying sleep disorder, such as narcolepsy, insomnia or untreated sleep apnea - Parent unable to complete study procedures

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States University of Colorado, Barbara Davis Center Aurora Colorado

Sponsors (2)

Lead Sponsor Collaborator
University of Colorado, Denver National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Duration of Sleep Change in duration of sleep before and after starting the advanced hybrid closed-loop system using surveys and activity watches End of study (6 months)
Secondary Impact on Diabetes Distress Change in diabetes-related distress using the validated Problem Areas in Diabetes survey End of study (6 months)
Secondary Impact on Quality of Life Change in quality of life using the validated survey Pediatric Quality of Life Inventory Diabetes Module (PedsQL) End of study (6 months)
Secondary Impact on Fear of Hypoglycemia Change in fear of hypoglycemia using the validated hypoglycemia fear survey End of study (6 months)
Secondary Impact on Perceptions of Diabetes Technology Change in diabetes technology perceptions using the validated survey Diabetes Technology Questionnaire End of study (6 months)
Secondary Impact on Hybrid Closed-Loop System Use Perceptions Change in perceptions of hybrid-closed loop systems using the validated INSPIRE survey End of study (6 months)
Secondary Impact of Sleep on Glycemic Variability Correlation of sleep duration and glycemic variability using hybrid closed loop device download to analyze time in range, time with low glucose and time with high glucose End of study (6 months)
See also
  Status Clinical Trial Phase
Recruiting NCT05653518 - Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes N/A
Enrolling by invitation NCT05515939 - Evaluating the InPen in Pediatric Type 1 Diabetes
Completed NCT05109520 - Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
Recruiting NCT04016987 - Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes N/A
Active, not recruiting NCT04190368 - Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes N/A
Recruiting NCT05413005 - Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus Early Phase 1
Active, not recruiting NCT04668612 - Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes N/A
Completed NCT02837094 - Enhanced Epidermal Antigen Specific Immunotherapy Trial -1 Phase 1
Recruiting NCT05414409 - The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action Phase 2
Recruiting NCT05670366 - The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes N/A
Active, not recruiting NCT05418699 - Real-life Data From Diabetic Patients on Closed-loop Pumps
Completed NCT04084171 - Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6 N/A
Recruiting NCT06144554 - Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
Recruiting NCT05153070 - Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes Phase 2
Recruiting NCT05379686 - Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes N/A
Completed NCT05281614 - Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D Early Phase 1
Withdrawn NCT04259775 - Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes N/A
Active, not recruiting NCT01600924 - Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
Completed NCT02914886 - Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS) Phase 4
Completed NCT02897557 - Insulet Artificial Pancreas Early Feasibility Study N/A